Key Drivers
- High gross margin
- Strong free cashflow
- Deferred-revenue risk
AIAI Summary
Align's investment case has shifted from a pure high-growth compounding story to a growth-at-a-discount/operational-improvement trade where upside now depends as much on ASP stabilization, margin recovery and working‑capital normalization as on case-volume expansion. Monitor ASP trends, receivables/deferred-revenue collection, and proof points of margin expansion or DSO/international conversion (or activist-led buybacks); continued ASP decline or recurring impairments would materially compress multiples.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High gross margin
- •Strong free cashflow
- •Deferred-revenue risk
ALGN is a cash-generative, high-margin company with low net debt and improving operating leverage but carries material deferred-revenue/receivables risk and appears richly valued.
Price Behavior
Key Price Behavior Insights:
- •Modest downtrend
- •Defined range
- •High volatility
Over the last month ALGN has rotated from a peak into a modest downtrend—pulling back from about $197.51 on 2026-02-11 to $173.18 by 2026-03-20, facing resistance near $190–$198 and support at $157–$164, so buyers defending support offer lower-risk entries while a break risks deeper correction.
Elevated intraperiod volatility with a pullback from $197.51 to $173.18 since 2026-02-11
Sentiment & News
Key News Insights:
- •Institutional buying
- •Elliott stake
- •Analyst momentum
Align Technology is seeing renewed institutional accumulation and analyst attention, capped by a new large Elliott stake that has spurred a stock jump and raises the prospect of activist-driven strategic pressure.
The combination of sustained fund inflows and an activist investor entry increases the likelihood of share-price upside and potential near-term strategic or governance moves
Similar Companies in Healthcare
Other companies in the same sector with AI ratings